Commercial Insurance Knowledge (Free subscription) | yesterday
The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. Bookmark To:
The Guardian (Free subscription) | yesterday
Financial crisis in Dubai has sent shockwaves through the world. Are we about to experience another recession? What's the problem? The FTSE's in free fall! Tens of billions of pounds wiped off share prices! Dubai's five-year Credit Default Swap index is rocketing! Heavens to Betsy, we're going back into recession! Panic, everybody, panic! Sorry I drifted off there. I was thinking about how wrong it...
BloggingStocks (Free subscription) | 29/11/2009
Filed under: Earnings reports , Forecasts , Economic data It's been reported that Canadian banks have fared better than their U.S. and European counterparts recently. The Bank of Montreal ( BMO ) did report strong fourth-quarter results last week. This week, analysts surveyed by Thomson Reuters expect competitor Royal Bank of Canada ( RY ) to post modest earnings growth as well, while Canadian Imperial...
The Guardian (Free subscription) | 26/11/2009
Debt crisis in millionaires' playground could herald new phase in global financial meltdown Share prices in the City suffered their biggest fall since March today amid fears that a debt crisis in the millionaires' playground of Dubai heralded a new phase in the global financial meltdown and a double-dip recession in 2010. With Alistair Darling admitting that he had been forced to rip up his already...
MarketIntelligenceCenter.com (Free subscription) | 26/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $54.64. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 54.16 and resistance in the 55.42 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
Yatter Matters (Free subscription) | 26/11/2009
What is Affodability? The question is triggered by two recent news releases from Scotia bank and the Royal Bank of Canada. Royal Bank qualifies their explanation of affordability with many rules, conditions and measures such as: size – the ’standard’ residence, types of taxes, and household income versus family income. Explanations loaded with conditions, make [...]
MarketIntelligenceCenter.com (Free subscription) | 25/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $54.28. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 53.47 and resistance in the 55.73 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
MarketIntelligenceCenter.com (Free subscription) | 24/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $55.07. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 54.54 and resistance in the 55.72 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
MarketIntelligenceCenter.com (Free subscription) | 23/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $53.94. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 53.37 and resistance in the 54.31 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
MarketIntelligenceCenter.com (Free subscription) | 19/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $55.08. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 54.49 and resistance in the 55.77 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
MarketIntelligenceCenter.com (Free subscription) | 18/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $55.15. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. The proprietary Key Risk Ranking for RY has declined from a 2 KEY Considerable Relative Risk to a 1 KEY High Relative Risk. This Key Ranking is determined daily and is a measure of the relative risk fo...
SeekingAlpha.com (Free subscription) | 17/11/2009
Streetwise Blog submits: A s regulators around the world debate potential reforms for the banking system, Royal Bank of Canada's ( RY ) chief executive is asking them to avoid the “piling on effect.” In a speech to the Canada-U.K. Chamber of Commerce in London on Monday, Gordon Nixon said he’s worried that policy makers in a variety of countries might impose their own specific requirements...
MarketIntelligenceCenter.com (Free subscription) | 17/11/2009
Royal Bank of Canada (NYSE: RY) closed yesterday at $54.91. So far the stock has hit a 52-week low of $20.51 and 52-week high of $55.58. Royal Bank of Canada stock has been showing support around 54.12 and resistance in the 55.98 range. Technical indicators for the stock are Bullish and S&P gives RY a neutral 3 STAR (out of 5) hold rating. RY appears on the Investors Observer Hedged Dividend Income...
VentureBeat (Free subscription) | 16/11/2009
Cell Biosciences, maker of software and other tools to learn more about how cells move and interact, has brought in $15 million of an anticipated $17.6 million fourth round of funding, according to a filing with the SEC. Based in Santa Clara, Calif., the company is backed by Domain Associates, Latterell Venture Partners, Vertical Group, Wellcome Trust, Novo A/S and the Royal Bank of Canada.
The Industry Standard (Free subscription) | 16/11/2009
Cell Biosciences , maker of software and other tools to learn more about how cells move and interact, has brought in $15 million of an anticipated $17.6 million fourth round of funding, according to a filing with the SEC. Based in Santa Clara, Calif., the company is backed by Domain Associates, Latterell Venture Partners, Vertical Group, Wellcome Trust, Novo A/S and the Royal Bank of Canada.
Videos